Chinese Journal of Pharmacovigilance ›› 2017, Vol. 14 ›› Issue (5): 304-308.

Previous Articles     Next Articles

Literature Analysis of 433 Cases of Drug-induced Pulmonary Diseases

MA Li, HAN Xiao-nian, HUANG Jing, PENG Li-rong*   

  1. Department. of Pharmacy, Xi’an Central Hospital, Shanxi Xi’an 710003, China
  • Received:2017-07-12 Revised:2017-07-12 Online:2017-05-20 Published:2017-07-12

Abstract: Objective To investigate the drugs leading to drug-induced pulmonary diseases and discuss their clinical characteristics, so as to provide reference for rational drug use in the clinic. Methods Literatures of drug-induced pulmonary diseases publicly reported in domestic medical journals from 1979 to 2015 were collected and analyzed statistically. Results A total of 227 relevant articles were identified, which reported 433 cases of drug-induced pulmonary diseases, involving cardiovascular drugs, anticancer drugs, non-steroidal anti-inflammatory drugs, anti-microbial agents and traditional Chinese medicine injections. The main syndromes were asthma, interstitial pneumonia, drug-induced pulmonary edema, pulmonary fibrosis,etc. Most cases improved after drug withdrawal and symptomatic treatment, but 53 patients died. Conclusion A variety of drugs can induce drug-related lung damages. It is necessary to be vigilant, so as to reduce the incidence of adverse reactions.

Key words: drug-induced pulmonary diseases, adverse reaction, safe drug use

CLC Number: